Zidovudine Capsule
Product Images NDC 65862-107

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zidovudine (NDC 65862-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Capsules Bottle))

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (100 mg Blister Carton (10 x 10 Unit-dose))
This is a prescription drug package of Zidovudine Capsules, USP manufactured by Aurobindo Pharma USA, Inc. The package contains 100 capsules in a child-resistant unit-dose format, each capsule containing 100 mg of zidovudine USP. The package insert contains information regarding the usual dosage and administration. It is recommended to store the package at 20-25°C and protect from moisture.*
FDA Label Image

Chemical Structure (Zidovudine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.